Trial site
Prisma Health Cancer Institute - Laurens
- 22running trials
- 5closed trials
The trials here
What the 29 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers6 trials
- Bladder cancer5 trials
- Lung cancer5 trials
- Colorectal cancer3 trials
- Metastatic breast cancer3 trials
- Chronic lymphocytic leukaemia2 trials
- Diffuse large B-cell lymphoma2 trials
- Kidney cancer2 trials
- Pancreatic cancer2 trials
- Sarcoma2 trials
- Triple-negative breast cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- and 11 more
- Phase
- Phase 314 trials
- Phase 29 trials
- Phase 2/33 trials
- Status
- Active, not recruiting20 trials
- Completed5 trials
- Recruiting2 trials
- Suspended2 trials
- Lead sponsor
- National Cancer Institute (NCI)17 trials
- SWOG Cancer Research Network5 trials
- ECOG-ACRIN Cancer Research Group4 trials
- Alliance for Clinical Trials in Oncology3 trials
Running trials
Recruiting
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Active, not recruiting
Active, not recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Active, not recruiting
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026